Delivery Order SPE2DB20D2002-SPE2DB22FL67X
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,139.16 for the supply of 4565048557 - Sodium Fluoride 1.1% Cream, 51 grams. The contract has an ultimate completion date of July 2, 2024 and was awarded on July 1, 2024 by the Defense agency known as the Medical Supply Chain, which is part of the Defense Logistics Agency (DLA) Troop Support. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $4,997.08 firm fixed-price contract is for the delivery of 1.1% sodium fluoride cream, 51 grams, with a performance period through December 30, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- The Defense Logistics Agency awarded a $1,733.83 firm fixed price delivery order to AmerisourceBergen Drug Corp for Sodium Fluoride 5000 Plus CRM 51GM, with an ultimate completion date of September 5, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The federal contract award is for $43,574.08 and was issued by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a wide range of pharmaceutical products and medical supplies. The $1,471.35 firm fixed-price contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. (parent company of Amerisourcebergen Drug Corp) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,945.16 Delivery Order contract is a Firm Fixed Price award with no set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a wide range of pharmaceutical products and medical supplies. The contract, valued at $15,120.32, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of pharmaceutical products and medical supplies. The award, valued at $1,135.62, is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen's parent company, Cencora, Inc. This IDC, worth up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, valued at $10,011.43, is a delivery order awarded under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $1,941.87, was issued by the Medical Supply Chain division of the Defense agency to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC serves as the primary vehicle for...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL67XDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,573.44 delivery order contract is for the supply of Sodium Fluoride 1.1% Cream, a pharmaceutical product. The contract is a Firm Fixed Price delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's and Department of Veterans Affairs' healthcare programs. The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, to various federal government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/31/22 |